Pfizer Inc
Close on Nov 20, 2026Market cap $156.17BP/E 36.1Yield 6.28%
Pfizer Operating Cash Flow: $835M in Q2 2026, down 243.5% from a year earlier.
Where the Q2 2026 figure comes from
Calculated from reported figures: quarter = year-to-date − previous year-to-date (cash flow statement)
Source: Form 10-Q (filed 2026-08-04) ↗
Reported in Database (SEC Form 10-K / 10-Q XBRL via lib/db.py).
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Operating Cash Flow ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 28, 2026 | 835 | -243.5% | Form 10-Q (filed 2026-08-04) ↗ |
| Q1 2026 | Mar 29, 2026 | 2,615 | +12.0% | Form 10-Q (filed 2026-05-05) ↗ |
| Q4 2025 | Dec 31, 2025 | 5,348 | -20.4% | Form 10-K (filed 2026-02-26) ↗ |
| Q3 2025 | Sep 28, 2025 | 4,603 | -31.4% | Form 10-Q (filed 2025-11-04) ↗ |
| Q2 2025 | Jun 29, 2025 | -582 | -67.3% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2025 | Mar 30, 2025 | 2,335 | +114.2% | Form 10-Q (filed 2025-05-05) ↗ |
| Q4 2024 | Dec 31, 2024 | 6,721 | +28.3% | Form 10-K (filed 2025-02-27) ↗ |
| Q3 2024 | Sep 29, 2024 | 6,714 | +94.3% | Form 10-Q (filed 2024-11-04) ↗ |
| Q2 2024 | Jun 30, 2024 | -1,781 | +47.4% | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | 1,090 | -10.1% | Form 10-Q (filed 2024-05-08) ↗ |
| Q4 2023 | Dec 31, 2023 | 5,240 | -38.9% | Form 10-K (filed 2024-02-22) ↗ |
| Q3 2023 | Oct 1, 2023 | 3,456 | -42.1% | Form 10-Q (filed 2023-11-08) ↗ |
| Q2 2023 | Jul 2, 2023 | -1,208 | -114.8% | Form 10-Q (filed 2023-08-09) ↗ |
| Q1 2023 | Apr 2, 2023 | 1,212 | -81.5% | Form 10-Q (filed 2023-05-10) ↗ |
| Q4 2022 | Dec 31, 2022 | 8,582 | +45.1% | Form 10-K (filed 2023-02-23) ↗ |
| Q3 2022 | Oct 2, 2022 | 5,974 | -44.8% | Form 10-Q (filed 2022-11-09) ↗ |
| Q2 2022 | Jul 3, 2022 | 8,170 | -27.7% | Form 10-Q (filed 2022-08-10) ↗ |
| Q1 2022 | Apr 3, 2022 | 6,541 | +44.1% | Form 10-Q (filed 2022-05-11) ↗ |
| Q4 2021 | Dec 31, 2021 | 5,914 | +5.1% | Form 10-K (filed 2022-02-24) ↗ |
| Q3 2021 | Oct 3, 2021 | 10,829 | +418.1% | Form 10-Q (filed 2021-11-12) ↗ |
| Q2 2021 | Jul 4, 2021 | 11,299 | +217.8% | Form 10-Q (filed 2021-08-12) ↗ |
| Q1 2021 | Apr 4, 2021 | 4,538 | +44.8% | Form 10-Q (filed 2021-05-13) ↗ |
| Q4 2020 | Dec 31, 2020 | 5,625 | +49.2% | Form 10-K (filed 2021-02-25) ↗ |
| Q3 2020 | Sep 27, 2020 | 2,090 | -53.7% | Form 10-Q (filed 2020-11-05) ↗ |
| Q2 2020 | Jun 28, 2020 | 3,555 | +36.2% | Form 10-Q (filed 2020-08-06) ↗ |
| Q1 2020 | Mar 29, 2020 | 3,133 | +84.5% | Form 10-Q (filed 2020-05-07) ↗ |
| Q4 2019 | Dec 31, 2019 | 3,769 | -20.5% | Form 10-K (filed 2020-02-27) ↗ |
| Q3 2019 | Sep 29, 2019 | 4,510 | -14.2% | Form 10-Q (filed 2019-11-07) ↗ |
| Q2 2019 | Jun 30, 2019 | 2,611 | -32.1% | Form 10-Q (filed 2019-08-08) ↗ |
| Q1 2019 | Mar 31, 2019 | 1,698 | -14.4% | Form 10-Q (filed 2019-05-09) ↗ |
| Q4 2018 | Dec 31, 2018 | 4,738 | -33.2% | Form 10-K (filed 2019-02-28) ↗ |
| Q3 2018 | Sep 30, 2018 | 5,259 | +7.6% | Form 10-Q (filed 2018-11-08) ↗ |
| Q2 2018 | Jul 1, 2018 | 3,847 | +18.7% | Form 10-Q (filed 2018-08-09) ↗ |
| Q1 2018 | Apr 1, 2018 | 1,983 | +25.2% | Form 10-Q (filed 2018-05-10) ↗ |
| Q4 2017 | Dec 31, 2017 | 7,089 | +17.3% | Form 10-K (filed 2019-02-28) ↗ |
| Q3 2017 | Oct 1, 2017 | 4,889 | +3.2% | Form 10-Q (filed 2018-11-08) ↗ |
| Q2 2017 | Jul 2, 2017 | 3,240 | -10.1% | Form 10-Q (filed 2018-08-09) ↗ |
| Q1 2017 | Apr 2, 2017 | 1,584 | -12.4% | Form 10-Q (filed 2018-05-10) ↗ |
| Q4 2016 | Dec 31, 2016 | 6,041 | +23.3% | Form 10-K (filed 2019-02-28) ↗ |
| Q3 2016 | Oct 2, 2016 | 4,737 | -5.6% | SEC Filing ↗ |
| Q2 2016 | Jul 3, 2016 | 3,606 | -11.8% | SEC Filing ↗ |
| Q1 2016 | Apr 3, 2016 | 1,808 | +165.9% | SEC Filing ↗ |
| Q4 2015 | Dec 31, 2015 | 4,898 | -12.5% | Form 10-K (filed 2017-02-23) ↗ |
| Q3 2015 | Sep 27, 2015 | 5,020 | +12.5% | SEC Filing ↗ |
| Q2 2015 | Jun 28, 2015 | 4,090 | +0.1% | SEC Filing ↗ |
| Q1 2015 | Mar 29, 2015 | 680 | -76.8% | SEC Filing ↗ |
| Q4 2014 | Dec 31, 2014 | 5,599 | -2.2% | Form 10-K (filed 2017-02-23) ↗ |
| Q3 2014 | Sep 28, 2014 | 4,463 | -24.4% | Form 10-Q (filed 2014-11-06) ↗ |
| Q2 2014 | Jun 29, 2014 | 4,087 | +8.8% | Form 10-Q (filed 2014-08-07) ↗ |
| Q1 2014 | Mar 30, 2014 | 2,935 | +27.4% | Form 10-Q (filed 2014-05-08) ↗ |
| Q4 2013 | Dec 31, 2013 | 5,724 | +15.7% | Form 10-K (filed 2015-02-27) ↗ |
| Q3 2013 | Sep 29, 2013 | 5,900 | +17.9% | Form 10-Q (filed 2014-11-06) ↗ |
| Q2 2013 | Jun 30, 2013 | 3,757 | -6.6% | Form 10-Q (filed 2014-08-07) ↗ |
| Q1 2013 | Mar 31, 2013 | 2,303 | -17.0% | Form 10-Q (filed 2014-05-08) ↗ |
| Q4 2012 | Dec 31, 2012 | 4,948 | -5.9% | Form 10-K (filed 2014-02-28) ↗ |
| Q3 2012 | Sep 30, 2012 | 5,003 | +12.7% | Form 10-Q (filed 2012-11-09) ↗ |
| Q2 2012 | Jul 1, 2012 | 4,021 | -31.8% | Form 10-Q (filed 2012-08-09) ↗ |
| Q1 2012 | Apr 1, 2012 | 2,774 | -40.2% | Form 10-Q (filed 2012-05-10) ↗ |
| Q4 2011 | Dec 31, 2011 | 5,261 | -15.9% | Form 10-K (filed 2012-02-28) ↗ |
| Q3 2011 | Oct 2, 2011 | 4,439 | -33.6% | Form 10-Q (filed 2011-11-10) ↗ |
| Q2 2011 | Jul 3, 2011 | 5,898 | +21.0% | Form 10-Q (filed 2011-08-11) ↗ |
| Q1 2011 | Apr 3, 2011 | 4,642 | -173.0% | Form 10-Q (filed 2011-05-12) ↗ |
| Q4 2010 | Dec 31, 2010 | 6,258 | +29.7% | Form 10-K (filed 2011-02-28) ↗ |
| Q3 2010 | Oct 3, 2010 | 6,683 | +63.0% | Form 10-Q (filed 2010-11-12) ↗ |
| Q2 2010 | Jul 4, 2010 | 4,873 | +8.0% | Form 10-Q (filed 2010-08-12) ↗ |
| Q1 2010 | Apr 4, 2010 | -6,360 | -302.1% | Form 10-Q (filed 2010-05-13) ↗ |
| Q4 2009 | Dec 31, 2009 | 4,825 | -19.2% | Form 10-K (filed 2010-02-26) ↗ |
| Q3 2009 | Sep 27, 2009 | 4,101 | +3.8% | Form 10-Q (filed 2009-11-05) ↗ |
| Q2 2009 | Jun 28, 2009 | 4,514 | – | Form 10-Q (filed 2010-05-13) ↗ |
| Q1 2009 | Mar 29, 2009 | 3,147 | – | Form 10-Q (filed 2010-05-13) ↗ |
| Q4 2008 | Dec 31, 2008 | 5,973 | – | Form 10-K (filed 2010-02-26) ↗ |
| Q3 2008 | Sep 28, 2008 | 3,952 | – | Form 10-Q (filed 2009-11-05) ↗ |
Breakdown
What makes up operating Cash Flow
Cite this data
StockData. (2026). Pfizer Operating Cash Flow ($M), quarterly Q3 2008–Q2 2026 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/db-fin-ocf
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.
See a number that looks wrong?